Correction to: Unveiling the next generation of MRI contrast agents: current insights and perspectives on ferumoxytol-enhanced MRI  

作　　者：Guangxiang Si Yue Du Peng Tang Gao Ma Zhaochen Jia Xiaoyue Zhou Dan Mu Yan Shen Yi Lu Yu Mao Chuan Chen Yan Li Ning Gu 

机构地区：[1]Jiangsu Key Laboratory for Biomaterials and Devices,School of Biological Science and Medical Engineering,Southeast University,Nanjing 210009,China [2]Key Laboratory for Bio-Electromagnetic Environment and Advanced Medical Theranostics,School of Biomedical Engineering and Informatics,Nanjing Medical University,Nanjing 211166,China [3]Department of Radiology,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China [4]MR Collaboration,Siemens Healthineers Ltd.,Shanghai 200126,China [5]Department of Radiology,Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School,Nanjing 210008,China [6]School of Mathematical Sciences,Capital Normal University,Beijing 100048,China [7]Nanjing Key Laboratory for Cardiovascular Information and Health Engineering Medicine,Institute of Clinical Medicine,Nanjing Drum Tower Hospital,Medical School,Nanjing University,Nanjing 210093,China

出　　处：《National Science Review》2024年第6期318-318,共1页国家科学评论（英文版）

摘　　要：In Table 1 of the original article titled‘Unveiling the next generation of MRI contrast agents:current insights and perspectives on ferumoxytol-enhanced MRI’(National Science Review,Volume 11,Issue 5,May 2024,nwae057,https://doi.org/10.1093/nsr/nwae057),there was an inadvertent error in the provided trade names and market status information of some contrast agents.The corrected version of Table 1 is presented below.

关 键 词：INSIGHT corrected MRI 

分 类 号：R563[医药卫生—呼吸系统] TP212.3[医药卫生—内科学]